SS Innovations International, Inc. (SSII)
NASDAQ (CM) NASDAQ (CM) Primary 
SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications
All Clinical Data Validated by Leading Third-Party CRO for Safety, Feasibility and Efficacy FORT LAUDERDALE, Fla., May 08, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends
Press Audio Overview: FORT LAUDERDALE, Fla., May 05, 2025 – PRISM MediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today reiterated guidance for the first quarter of 2025.
SS Innovations Announces Chief Financial Officer Transition
Listened: Thomas Wolff · SS Innovations Announces Chief Financial Officer Transition Fort Lauderdale, FL, May 2, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations to Uplist to Nasdaq
Listened: Fort Lauderdale, FL, April 24, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Achieves Significant Milestones in 2024
FORT LAUDERDALE, FL, March 31, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine
Fort Lauderdale, Fla. March 28, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System
Fort Lauderdale, FL, March 27, 2025 – PRISM MediaWire – SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative robotic surgical technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it successfully performed India's first North-to-South robotic cardiac telesurgery.
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
Fort Lauderdale, Fla., January 13, 2025 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting
FORT LAUDERDALE, Fla., Dec. 11, 2024 – PRISM MediaWire – SS Innovations International, Inc.
India's First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way
FORT LAUDERDALE, Fla., Dec. 10, 2024 – PRISM MediaWire – SS Innovations International, Inc.
SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia
Fort Lauderdale, Fla., November 26, 2024 – PRISM MediaWire – SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has successfully performed the first-ever robotic cardiac surgery in Indonesia.
SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board
Tim Adams to serve as Independent Board Director FORT LAUDERDALE, FL, September 30, 2024 – PRISM MediaWire – SS Innovations International, Inc.
